# Topical Steroid Formulation and Wet Wraps

> **NCT02680301** · PHASE4 · COMPLETED · sponsor: **Seton Healthcare Family** · enrollment: 40 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** 0.1% triamcinolone CREAM
- **DRUG:** 0.1% triamcinolone OINTMENT

## Key facts

- **NCT ID:** NCT02680301
- **Lead sponsor:** Seton Healthcare Family
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-03
- **Final completion:** 2018-06-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02680301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02680301, "Topical Steroid Formulation and Wet Wraps". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02680301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*